| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | -0.064 | 0.07 |
| mRNA | AC220 | GDSC1000 | pan-cancer | AAC | 0.061 | 0.07 |
| mRNA | Bexarotene | GDSC1000 | pan-cancer | AAC | -0.063 | 0.07 |
| mRNA | GW843682X | CTRPv2 | pan-cancer | AAC | -0.061 | 0.07 |
| mRNA | KIN001-244 | GDSC1000 | pan-cancer | AAC | 0.055 | 0.07 |
| mRNA | PI-103 | GDSC1000 | pan-cancer | AAC | 0.053 | 0.07 |
| mRNA | OSI-027 | GDSC1000 | pan-cancer | AAC | 0.054 | 0.07 |
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.065 | 0.08 |
| mRNA | indisulam | CTRPv2 | pan-cancer | AAC | -0.056 | 0.08 |
| mRNA | CCT007093 | GDSC1000 | pan-cancer | AAC | -0.059 | 0.08 |